Literature DB >> 25769394

Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.

Eric B Dammer1, Martin Göttle2, Duc M Duong1, John Hanfelt3, Nicholas T Seyfried1, H A Jinnah2,4.   

Abstract

The importance of specific pathways of purine metabolism for normal brain function is highlighted by several inherited disorders, such as Lesch-Nyhan disease (LND). In this disorder, deficiency of the purine recycling enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGprt), causes severe neurological and behavioral abnormalities. Despite many years of research, the mechanisms linking the defect in purine recycling to the neurobehavioral abnormalities remain unclear. In the current studies, an unbiased approach to the identification of potential mechanisms was undertaken by examining changes in protein expression in a model of HGprt deficiency based on the dopaminergic rat PC6-3 line, before and after differentiation with nerve growth factor (NGF). Protein expression profiles of 5 mutant sublines carrying different mutations affecting HGprt enzyme activity were compared to the HGprt-competent parent line using the method of stable isotopic labeling by amino acids in cell culture (SILAC) followed by denaturing gel electrophoresis with liquid chromatography and tandem mass spectrometry (LC-MS/MS) of tryptic digests, and subsequent identification of affected biochemical pathways using the Database for Annotation, Visualization and Integrated Discovery (DAVID) functional annotation chart analysis. The results demonstrate that HGprt deficiency causes broad changes in protein expression that depend on whether the cells are differentiated or not. Several of the pathways identified reflect predictable consequences of defective purine recycling. Other pathways were not anticipated, disclosing previously unknown connections with purine metabolism and novel insights into the pathogenesis of LND.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine neurons; Hypoxanthine–guanine phosphoribosyltransferase; Lesch–Nyhan disease; Proteome

Mesh:

Substances:

Year:  2015        PMID: 25769394      PMCID: PMC4390545          DOI: 10.1016/j.ymgme.2015.02.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  62 in total

Review 1.  Rho and Ras GTPases in axon growth, guidance, and branching.

Authors:  Alan Hall; Giovanna Lalli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 2.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

3.  Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

Authors:  Jasper E Visser; Doug W Smith; Sheryl S Moy; George R Breese; Theodore Friedmann; Jeffrey D Rothstein; H A Jinnah
Journal:  Brain Res Dev Brain Res       Date:  2002-02-28

4.  Decelerated rate of dendrite outgrowth from dopaminergic neurons in primary cultures from brains of hypoxanthine phosphoribosyltransferase-deficient knockout mice.

Authors:  P Boer; S Brosh; L Wasserman; I Hammel; E Zoref-Shani; O Sperling
Journal:  Neurosci Lett       Date:  2001-04-27       Impact factor: 3.046

5.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

6.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.

Authors:  Martin Göttle; Heike Burhenne; Diane Sutcliffe; H A Jinnah
Journal:  J Neurochem       Date:  2013-08-18       Impact factor: 5.372

Review 7.  Trophic effects of purines in neurons and glial cells.

Authors:  M P Rathbone; P J Middlemiss; J W Gysbers; C Andrew; M A Herman; J K Reed; R Ciccarelli; P Di Iorio; F Caciagli
Journal:  Prog Neurobiol       Date:  1999-12       Impact factor: 11.685

8.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

9.  Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.

Authors:  M G García; J G Puig; R J Torres
Journal:  Brain Behav Immun       Date:  2009-07-25       Impact factor: 7.217

Review 10.  The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.

Authors:  A A Baumeister; G D Frye
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

View more
  3 in total

1.  Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.

Authors:  Huidi Liu; Zheng Zeng; Siwen Wang; Ting Li; Emilio Mastriani; Qing-Hai Li; Hong-Xia Bao; Yu-Jie Zhou; Xiaoyu Wang; Yongfang Liu; Wei Liu; Sijing Hu; Shan Gao; Miao Yu; Yingying Qi; Zhihang Shen; Hongyue Wang; Tingting Gao; Lingqin Dong; Randal N Johnston; Shu-Lin Liu
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

Review 2.  Formate metabolism in health and disease.

Authors:  Matthias Pietzke; Johannes Meiser; Alexei Vazquez
Journal:  Mol Metab       Date:  2019-07-30       Impact factor: 7.422

3.  A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer.

Authors:  Courtney D Dill; Eric B Dammer; Ti'ara L Griffen; Nicholas T Seyfried; James W Lillard
Journal:  iScience       Date:  2021-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.